Logo image of DQ

DAQO NEW ENERGY CORP-ADR (DQ) Stock Fundamental Analysis

USA - NYSE:DQ - US23703Q2030 - ADR

28.96 USD
-0.55 (-1.86%)
Last: 10/3/2025, 8:04:00 PM
29.75 USD
+0.79 (+2.73%)
After Hours: 10/3/2025, 8:04:00 PM
Fundamental Rating

4

Overall DQ gets a fundamental rating of 4 out of 10. We evaluated DQ against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While DQ has a great health rating, there are worries on its profitability. While showing a medium growth rate, DQ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DQ has reported negative net income.
In the past year DQ has reported a negative cash flow from operations.
Of the past 5 years DQ 4 years were profitable.
Of the past 5 years DQ 4 years had a positive operating cash flow.
DQ Yearly Net Income VS EBIT VS OCF VS FCFDQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of -6.19%, DQ is doing worse than 66.96% of the companies in the same industry.
DQ has a worse Return On Equity (-9.00%) than 65.18% of its industry peers.
Industry RankSector Rank
ROA -6.19%
ROE -9%
ROIC N/A
ROA(3y)8.12%
ROA(5y)11.44%
ROE(3y)12.99%
ROE(5y)18.09%
ROIC(3y)N/A
ROIC(5y)N/A
DQ Yearly ROA, ROE, ROICDQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DQ Yearly Profit, Operating, Gross MarginsDQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

DQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
DQ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DQ has been reduced compared to 5 years ago.
The debt/assets ratio for DQ is higher compared to a year ago.
DQ Yearly Shares OutstandingDQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
DQ Yearly Total Debt VS Total AssetsDQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

DQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC10.17%
DQ Yearly LT Debt VS Equity VS FCFDQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

DQ has a Current Ratio of 5.65. This indicates that DQ is financially healthy and has no problem in meeting its short term obligations.
DQ has a Current ratio of 5.65. This is in the better half of the industry: DQ outperforms 78.57% of its industry peers.
DQ has a Quick Ratio of 5.27. This indicates that DQ is financially healthy and has no problem in meeting its short term obligations.
DQ's Quick ratio of 5.27 is amongst the best of the industry. DQ outperforms 84.82% of its industry peers.
Industry RankSector Rank
Current Ratio 5.65
Quick Ratio 5.27
DQ Yearly Current Assets VS Current LiabilitesDQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for DQ have decreased strongly by -472.55% in the last year.
The Revenue for DQ has decreased by -62.85% in the past year. This is quite bad
Measured over the past years, DQ shows a very strong growth in Revenue. The Revenue has been growing by 24.07% on average per year.
EPS 1Y (TTM)-472.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.02%
Revenue 1Y (TTM)-62.85%
Revenue growth 3Y-15.05%
Revenue growth 5Y24.07%
Sales Q2Q%-65.81%

3.2 Future

The Earnings Per Share is expected to grow by 32.02% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 32.99% on average over the next years. This is a very strong growth
EPS Next Y35%
EPS Next 2Y38.39%
EPS Next 3Y36.91%
EPS Next 5Y32.02%
Revenue Next Year-41.35%
Revenue Next 2Y3.28%
Revenue Next 3Y14.53%
Revenue Next 5Y32.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DQ Yearly Revenue VS EstimatesDQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
DQ Yearly EPS VS EstimatesDQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 10 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DQ. In the last year negative earnings were reported.
Also next year DQ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DQ Price Earnings VS Forward Price EarningsDQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DQ Per share dataDQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as DQ's earnings are expected to grow with 36.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.39%
EPS Next 3Y36.91%

More info and screens

0

5. Dividend

5.1 Amount

DQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DAQO NEW ENERGY CORP-ADR

NYSE:DQ (10/3/2025, 8:04:00 PM)

After market: 29.75 +0.79 (+2.73%)

28.96

-0.55 (-1.86%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-26 2025-08-26/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners48.73%
Inst Owner Change0.14%
Ins Owners13.38%
Ins Owner ChangeN/A
Market Cap1.90B
Analysts81.05
Price Target30.02 (3.66%)
Short Float %26.53%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-30.26%
Min EPS beat(2)-49.47%
Max EPS beat(2)-11.05%
EPS beat(4)0
Avg EPS beat(4)-68.79%
Min EPS beat(4)-188.13%
Max EPS beat(4)-11.05%
EPS beat(8)0
Avg EPS beat(8)-85.33%
EPS beat(12)0
Avg EPS beat(12)-71.61%
EPS beat(16)2
Avg EPS beat(16)-53.68%
Revenue beat(2)0
Avg Revenue beat(2)-40.99%
Min Revenue beat(2)-48.06%
Max Revenue beat(2)-33.93%
Revenue beat(4)2
Avg Revenue beat(4)-13.98%
Min Revenue beat(4)-48.06%
Max Revenue beat(4)23.53%
Revenue beat(8)2
Avg Revenue beat(8)-19.14%
Revenue beat(12)3
Avg Revenue beat(12)-18.89%
Revenue beat(16)6
Avg Revenue beat(16)-15.18%
PT rev (1m)7.11%
PT rev (3m)20.87%
EPS NQ rev (1m)19.53%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)11.39%
EPS NY rev (3m)15.59%
Revenue NQ rev (1m)9.26%
Revenue NQ rev (3m)29%
Revenue NY rev (1m)-1.73%
Revenue NY rev (3m)0.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.21
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-5.84
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)-6.34
FCFYN/A
OCF(TTM)-3.99
OCFYN/A
SpS9.02
BVpS65.77
TBVpS65.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.19%
ROE -9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)8.12%
ROA(5y)11.44%
ROE(3y)12.99%
ROE(5y)18.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 75.01%
Cap/Sales 26.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.65
Quick Ratio 5.27
Altman-Z N/A
F-Score3
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)714.5%
Cap/Depr(5y)594.49%
Cap/Sales(3y)38.14%
Cap/Sales(5y)32.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-472.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.02%
EPS Next Y35%
EPS Next 2Y38.39%
EPS Next 3Y36.91%
EPS Next 5Y32.02%
Revenue 1Y (TTM)-62.85%
Revenue growth 3Y-15.05%
Revenue growth 5Y24.07%
Sales Q2Q%-65.81%
Revenue Next Year-41.35%
Revenue Next 2Y3.28%
Revenue Next 3Y14.53%
Revenue Next 5Y32.99%
EBIT growth 1Y-662.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.83%
EBIT Next 3Y48.71%
EBIT Next 5Y42.53%
FCF growth 1Y-119.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.37%
OCF growth 3YN/A
OCF growth 5YN/A